Drum-Assisted Therapy for Native Americans
Drum-Assisted Recovery Therapy for Native Americans
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90017
- United American Indian Involvement, Inc.
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- meeting Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR; American Psychiatric Association, 2000) criteria of current alcohol or drug abuse or dependence
- self-identifying as at least ¼ American Indian/Alaska Native heritage
- seeking treatment for alcohol or drug abuse
- being at least 18 years old. Clients will be assessed for suitability for outpatient treatment.
Exclusion Criteria:
- have a psychiatric conditions that is not suitable for outpatient treatment (e.g., if they require inpatient rehabilitation treatment, have significant psychiatric disorders, require medical detoxification, or have significant medical problems)
- have a current suicidal ideation/plan as assessed by the ASI or BSI
- are mandated by the court to obtain treatment for substance abuse where such mandate requires the results of urine toxicology tests to be reported to the court
- expectation that the participant will fail to complete the study protocol due to probable incarceration or relocation from the clinic area.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Treatment-As-Usual
Substance Abuse treatment typically received
|
Participants will receive typical substance abuse behavior treatment interventions typically provided to patients including individual counseling, group therapy, and standard culturally-based interventions.
|
|
EXPERIMENTAL: DARTNA
12-week DARTNA program
|
3-hour protocol provided 2x/week over 12 weeks
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Drug and Alcohol Use as a Measure of Treatment Effectiveness
Time Frame: Change from Baseline in Drug and Alcohol use at 6 months
|
Urine drug screens and breathalyzers will be obtained from patients in order to determine their recent drug and alcohol use.
|
Change from Baseline in Drug and Alcohol use at 6 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knowledge of Alcoholics Anonymous Concepts as a Measure of Protocol Comprehension
Time Frame: Change from Baseline in Knowledge of Alcoholics Anonymous at 12 weeks
|
The General Alcoholics Anonymous Tools of Recovery (GAATOR 2.1) will be provided in order to determine and track patient's knowledge of the 12-steps during their participation in the DARTNA treatment program.
|
Change from Baseline in Knowledge of Alcoholics Anonymous at 12 weeks
|
|
Mental Health and Psychosocial Characteristics as Measured by the Addiction Severity Index, Native American Version and Brief Symptom Inventory.
Time Frame: Change from Baseline in Mental Health and psychosocial characteristics at 6 months
|
The Addiction Severity Index, Native American Version will be utilized to assess problem severity in alcohol use, drug use, employment, family and social relationships, legal, psychological, and medical status.
In addition, additional information with regards to mental health characteristics will be obtained from the Brief Symptom Inventory.
|
Change from Baseline in Mental Health and psychosocial characteristics at 6 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Daniel L Dickerson, D.O., M.P.H., University of California, Los Angeles
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (ACTUAL)
Primary Completion
Study Completion (ACTUAL)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- DARTNA
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.